| Date Filed | Type | Description |
| 07/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/22/2022 |
SC 13D/A
| Tenshi Healthcare Pte. Ltd. reports a 25.6% stake in Outlook Therapeutics, Inc. |
| 02/01/2022 |
SC 13D/A
| BioLexis Pte Ltd. reports a 35.7% stake in Outlook Therapeutics, Inc. |
| 12/01/2021 |
SC 13D/A
| BioLexis Pte Ltd. reports a 35.5% stake in Outlook Therapeutics, Inc. |
| 02/02/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/24/2020 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 65.3% stake in Outlook Therapeutics, Inc. |
| 02/27/2020 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 47.8% stake in Outlook Therapeutics, Inc. |
| 01/31/2020 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 51.6% stake in Outlook Therapeutics, Inc. |
| 12/30/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/19/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 62.4% stake in Outlook Therapeutics, Inc. |
| 04/16/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 70.9% stake in Outlook Therapeutics, Inc. |
| 02/05/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 80.1% stake in Outlook Therapeutics, Inc. |
| 01/03/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 79.5% stake in Outlook Therapeutics, Inc. |
| 11/09/2018 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 78.1% stake in Oncobiologics, Inc. |
| 07/20/2018 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 77.7% stake in Oncobiologics, Inc. |
| 06/25/2018 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 77.5% stake in Oncobiologics, Inc. |
| 11/01/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/18/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |